What should I do about edema from radiation therapy for throat cancer?

Written by Li Rui
Otolaryngology
Updated on December 22, 2024
00:00
00:00

After radiotherapy for laryngeal cancer, or during the process of radiotherapy, edema may occur, mainly mucosal edema in the pharyngeal region, and some patients may also experience swelling of the soft tissues in the neck. In such cases, it is recommended to visit an otolaryngology department where a laryngoscopy and routine blood tests can be conducted to help assess the severity of the condition. Generally, nebulizer therapy can be chosen. If there is an accompanying acute bacterial inflammation, antibiotics may need to be considered. Most patients will see a gradual reduction in the degree of swelling after timely medication treatment, but overall, complete recovery requires a relatively long period of time.

Other Voices

doctor image
home-news-image
Written by Xu Qing Tian
Otolaryngology
51sec home-news-image

Recurrence rate after total laryngectomy for throat cancer

Laryngeal cancer is a common disease in otolaryngology and a relatively prevalent malignant tumor. Patients who undergo total laryngectomy often have advanced laryngeal tumors, which block the esophagus or pharynx and have tumor tissues too large for partial removal. The likelihood of recurrence after tumor resection varies from patient to patient, depending on the radiotherapy and chemotherapy administered post-operatively, as well as individual physical constitutions, which can alter recurrence rates. Generally, we recommend that patients undergo a laryngoscopic check-up every three to six months and a CT scan of the larynx post-surgery, to enable timely detection and treatment, aiming for early control and intervention in case of potential recurrence.

doctor image
home-news-image
Written by Deng Bang Yu
Otolaryngology
51sec home-news-image

Does throat cancer require the removal of the throat?

Laryngeal cancer is a malignant tumor in the larynx, clinically mainly squamous cell carcinoma. The treatment of laryngeal cancer primarily involves comprehensive treatment centered around surgery, which is adapted according to the type of laryngeal cancer the patient has and the extent of the lesion. For some early-stage tumors, such as carcinoma in situ or T1 stage tumors, treatment often involves local removal with a laser or radiation therapy, after which a cure is achieved without the need for partial or total laryngectomy. This approach preserves the function of the larynx, especially the function of phonation. In summary, the treatment of laryngeal cancer should be based on its specific circumstances and does not necessarily involve the removal or excision of the larynx.

doctor image
home-news-image
Written by Xu Qing Tian
Otolaryngology
52sec home-news-image

What should I do if I have a cough from throat cancer?

Laryngeal cancer is a common malignant tumor in otolaryngology. Patients with laryngeal cancer often experience coughs primarily because of the presence of tumors at the glottis, which then cause irritative coughs. For patients with the aforementioned symptoms, we should first diagnose the disease using a laryngoscope and CT scans of the throat area. Subsequently, it is crucial to remove the tumor through surgery as early as possible to achieve a complete cure. Post-surgery, patients usually undergo radiotherapy and chemotherapy. In the early stages before surgery, when the patient suffers from severe coughing, medications that clear the throat and benefit the voice can be used to alleviate the symptoms and reduce the patient's suffering. (Medication should be administered under the guidance of a doctor.)

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 1sec home-news-image

Does CEA increase in throat cancer?

In the blood tests of some laryngeal cancer patients, an increase in the CEA index may be observed, but most laryngeal cancer patients do not exhibit abnormal CEA levels. This is because laryngeal cancer is a common malignant tumor in the head and neck region, and currently, there are no specific tumor markers clinically for laryngeal cancer. CEA, also known as carcinoembryonic antigen, is a tumor marker that is most often elevated in the bodies of patients with malignant tumors. Clinically, an increase in the CEA level is commonly seen in malignant tumors of the gastrointestinal tract, thoracic malignancies, malignancies in the female urogenital system, and some tumors in the male urogenital system. However, in patients with head and neck malignancies, this marker is not commonly elevated.

doctor image
home-news-image
Written by Deng Bang Yu
Otolaryngology
56sec home-news-image

How is advanced malignant throat cancer treated?

Laryngeal cancer is a malignant tumor in the larynx, mainly squamous cell carcinoma. In advanced stages of laryngeal cancer, the main issues are malignant ulcers in the laryngeal area, followed by tumor proliferation, bleeding, and then blockage of the airway by the tumor mass, leading to respiratory difficulties and cachexia throughout the body. Therefore, the primary treatment for advanced malignant tumors is to maintain airway patency, mainly through tracheotomy; secondly, pain management and analgesic treatment are provided to improve the patient’s quality of life; thirdly, nutritional support is provided to the patient, including the insertion of a gastric tube or even parenteral nutrition via intravenous feeding. Overall, the treatment of advanced malignant tumors primarily focuses on improving quality of life and alleviating patient suffering.